Jeffrey Lebensburger

21PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Infant and child healthHaematologyCardiology (incl. cardiovascular diseases)People with disability
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 17, 2026
A Multicenter, Open-Label, Phase 2 Trial Comparing Crizanlizumab Combined With Standard Therapy to Standard Therapy Alone on Renal Function in Patients With Sickle Cell Nephropathy (STEADFAST).

|Mar 23, 2026
The Longitudinal Effect of APOL1 Risk Alleles on Sickle Cell Anemia-Associated Kidney Function.

Sara R Rashkin, Guolian Kang, Clifford M Takemoto

|Jan 30, 2026
Increased Endothelin-1 and High-Risk APOL1 Variants Contribute to Albuminuria in Pediatric and Young Adults with Sickle Cell Anemia.

Malgorzata Kasztan, Guolian Kang, Davide Botta

|Jul 15, 2024
Prevalence, Mortality, and Access to Care for Chronic Kidney Disease in Medicaid-Enrolled Adults With Sickle Cell Disease in California: Retrospective Cohort Study.

Jhaqueline Valle, Jeffrey D Lebensburger, Pranav S Garimella

|Aug 31, 2023
Kidney failure outcomes in children and young adults with sickle cell disease in the United States Renal Data System.

Rima S Zahr, Kenneth I Ataga, Jeffrey D Lebensburger

|Jan 11, 2023
The relationship between pain and sleep in pediatric sickle cell disease.

Dakshin Padmanabhan, Tiffany Tucker, Donna Murdaugh

Pageof 4

Frequent Collaborators

6 joint publications

Rima Zahr

5 joint publications

Kenneth I Ataga

3 joint publications

Sara Rashkin

2 joint publications

Santosh L Saraf